New study reveals the existence of biases in the decision‐making process when referring patients for catheter ablation as supraventricular first‐line treatment. @chluize @codietrich#AHAJournals https://t.co/lQwDhGy6sk
Better physician education about the positive impact of catheter ablation for SVT may help improve use as a first-line option, @DrJCheungEP says @TCTMD https://t.co/OsoJDq1fAE
@kimpkat @renatagilamb Doutora, achei bastante elegante a proposta do deputado em convidá-la para um debate transparente e saudável. Assim a senhora poderá discutir e expor os motivos pelos quais o seu entendimento diverge do parlamentar. Ótima oportunidade para convencer o incrédulo povo brasileiro
Lack of result replication is well known in science, especially for observational studies that claim for treatment effects, either efficacy or harm. I wonder the proportion of observational studies to be retracted if all were questioned such as this registry was.
Let’s talk about what happens if you get COVID19 and recover. Are you immune to the disease? How long does the immunity last? And what does that mean for your life and for the public health and economy of our society? 1/
Usama Riaz is another #CoronaHero who we lost in this #COVID19 battle ... never forget how the lack of protective equipment took the lives of healthcare professionals, including young ones with such bright futures 🙏